Driving Innovation and Job Growth Through the Life Sciences Industry
Author: United States. Congress. Joint Economic Committee
Publisher:
Published: 2011
Total Pages: 60
ISBN-13:
DOWNLOAD EBOOK →Author: United States. Congress. Joint Economic Committee
Publisher:
Published: 2011
Total Pages: 60
ISBN-13:
DOWNLOAD EBOOK →Author: Philip A. Rea
Publisher: Cambridge University Press
Published: 2018-02
Total Pages: 557
ISBN-13: 1107130905
DOWNLOAD EBOOK →Addresses in roughly equal measure the science and management behind several recent marketable biomedical innovations.
Author: Tomasz Mroczkowski
Publisher: Pearson Education
Published: 2011-07-07
Total Pages: 354
ISBN-13: 0132172968
DOWNLOAD EBOOK →The global center of gravity in life sciences innovation is rapidly shifting to emerging economies. In The New Players in Life Science Innovation, Tomasz Mroczkowski explains how China and other new economic powers are rapidly gaining leadership positions, and thoroughly assesses the implications. Mroczkowski discusses the sophisticated innovation strategies and reforms these nations have implemented: approaches that don't rely on market forces alone, and are achieving remarkable success. Next, he previews the emerging global "bio-economy," in which life science discoveries will be applied pervasively in markets ranging from health to fuels. As R&D in the West becomes increasingly costly, Mroczkowski introduces new options for partnering with new players in the field. He thoroughly covers the globalization of clinical trials, showing how it offers opportunities that go far beyond cost reduction, and assessing the unique challenges it presents. Offering examples from China to Dubai to India, he carefully assesses the business models driving today's newest centers of innovation. Readers will find up-to-date coverage of bioparks, technology zones, and emerging clusters, and realistic assessments of global R&D collaboration strategies such as those of Eli Lilly, Merck, Novartis, and IBM. With innovation-driven industries increasingly dominating the global economy, this book's insights are indispensable for every R&D decision-maker and investor.
Author: United States. Congress. Senate. Committee on the Judiciary
Publisher:
Published: 2011
Total Pages: 208
ISBN-13:
DOWNLOAD EBOOK →Consists mainly of text from the book, Reconciling with the Taliban?
Author: James F. Jordan
Publisher: CRC Press
Published: 2014-11-05
Total Pages: 250
ISBN-13: 1482210134
DOWNLOAD EBOOK →Innovation is the translation of a new method, idea, or product into reality and profit. It is a process of connected steps that accumulates into your brand or reputation. However, there can be many pitfalls and wrong turns on the road to realizing this goal. Innovation, Commercialization, and Start-Ups in Life Sciences details the methodologies ne
Author: Marian V. Jones
Publisher: Edward Elgar Publishing
Published: 2011-11-01
Total Pages: 361
ISBN-13: 1849808201
DOWNLOAD EBOOK →'The processes of internationalization, innovation and venture-creation in high-technology new ventures are inextricably intertwined. This is particularly true in the uncertain and troubled waters of the life sciences industry where startups with very uncertain futures are required to face significant challenges in short windows of opportunity. Navigating these waters is not straightforward, either for those immediately involved in it, or for those trying to understand it. This book is a must-read for anyone who is serious about understanding entrepreneurship in the biotechnology industry.' Alberto Onetti, CrESIT (Research Center for Innovation and Life Science Management), Italy In this thought-provoking book, leading experts explore why international entrepreneurship is important to the life sciences industry. From multi-disciplinary and cross-national perspectives, they question why international entrepreneurship scholars might usefully invest interest in research focused on one specific industry context. The book addresses contemporary challenges of relevance to life science firms and draws on leading-edge debates in international entrepreneurship research. Topics include: the nature of the born-global firm; the development of international capabilities and competencies; the role of local and international partnerships and alliances; competitiveness, opportunity recognition and orientation; and the role of specialized complementary assets in internationalization. It concludes by proposing an agenda for future research across the underpinning fields of innovation, entrepreneurship and internationalization. This book will prove a stimulating read for academics, students and researchers with an interest in international business, management and entrepreneurship, as well as for practitioners in the health professions or life sciences academics who are, or may become, entrepreneurs.
Author: United States. Congress. Senate. Committee on Small Business and Entrepreneurship
Publisher:
Published: 2014
Total Pages: 72
ISBN-13:
DOWNLOAD EBOOK →Author: Alberto Onetti
Publisher: Routledge
Published: 2014-03-21
Total Pages: 212
ISBN-13: 1317919130
DOWNLOAD EBOOK →Most books on the biotechnology industry focus on scientific and technological challenges, ignoring the entrepreneurial and managerial complexities faced bio-entrepreneurs. The Business Models for Life Science Firms aims to fill this gap by offering managers in this rapid growth industry the tools needed to design and implement an effective business model customized for the unique needs of research intensive organizations. Onetti and Zucchella begin by unpacking the often-used ‘business model’ term, examining key elements of business model conceptualization and offering a three tier approach with a clear separation between the business model and strategy: focus, exploring the different activities carried out by the organization; locus, evaluating where organizational activities are centered; and modus, testing the execution of the organization’s activities. The business model thus defines the unique way in which a company delivers on its promise to its customers. The theory and applications adopt a global approach, offering business cases from a variety of biotech companies around the world.
Author: Francoise Simon
Publisher: John Wiley & Sons
Published: 2017-10-16
Total Pages: 322
ISBN-13: 1119216176
DOWNLOAD EBOOK →A comprehensive overview of the new business context for biopharma companies, featuring numerous case studies and state-of-the-art marketing models Biotechnology has developed into a key innovation driver especially in the field of human healthcare. But as the biopharma industry continues to grow and expand its reach, development costs are colliding with aging demographics and cost-containment policies of private and public payers. Concurrently, the development and increased affordability of sophisticated digital technologies has fundamentally altered many industries including healthcare. The arrival of new information technology (infotech) companies on the healthcare scene presents both opportunities and challenges for the biopharma business model. To capitalize on new digital technologies from R&D through commercialization requires industry leaders to adopt new business models, develop new digital and data capabilities, and partner with innovators and payers worldwide. Written by two experts, both of whom have had decades of experience in the field, this book provides a comprehensive overview of the new business context and marketing models for biotech companies. Informed by extensive input by senior biotech executives and leading consultancies serving the industry, it analyzes the strategies and key success factors for the financing, development, and commercialization of novel therapeutic products, including strategies for engagement with patients, physicians and healthcare payers. Throughout case studies provide researchers, corporate marketers, senior managers, consultants, financial analysts, and other professionals involved in the biotech sector with insights, ideas, and models. JACQUALYN FOUSE, PhD, RETIRED PRESIDENT AND CHIEF OPERATING OFFICER, CELGENE “Biotech companies have long been innovators, using the latest technologies to enable cutting edge science to help patients with serious diseases. This book is essential to help biotech firms understand how they can–and must–apply the newest technologies including disruptive ones, alongside science, to innovate and bring new value to the healthcare system.” BRUCE DARROW, MD, PhD, CHIEF MEDICAL INFORMATION OFFICER, MOUNT SINAI HEALTH SYSTEM “Simon and Giovannetti have written an essential user’s manual explaining the complicated interplay of the patients who deserve cutting-edge medical care, the biotechnology companies (big and small) creating the breakthroughs, and the healthcare organizations and clinicians who bridge those worlds.” EMMANUEL BLIN, FORMER CHIEF STRATEGY OFFICER AND SENIOR VICE PRESIDENT, BRISTOL-MYERS SQUIBB “If you want to know where biopharma is going, read this book! Our industry is facing unprecedented opportunities driven by major scientific breakthroughs, while transforming itself to address accelerated landscape changes driven by digital revolutions and the emergence of value-based healthcare worldwide. In this ever-changing context, we all need to focus everything we do on the patients. They are why we exist as an industry, and this is ultimately what this insightful essay is really about.” JOHN MARAGANORE, PRESIDENT AND CHIEF EXECUTIVE OFFICER, ALNYLAM PHARMACEUTICALS “Since the mapping of the human genome was completed nearly 15 years ago, the biotechnology industry has led the rapid translation of raw science to today’s innovative medicines. However, the work does not stop in the lab. Delivering these novel medicines to patients is a complex and multifaceted process, which is elegantly described in this new book.”
Author: Avo Schönbohm
Publisher: Springer Nature
Published:
Total Pages: 272
ISBN-13: 3031477685
DOWNLOAD EBOOK →